Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Trump reveals pharma reform priorities in drug pricing executive order
Pharma Voice
Thursday, April 24, 2025 - 10:40am
tags:
Donald Trump, drug pricing, executive order
Zealand Pharma Hires Lilly Executive as Biotech Ramps Up in Obesity
MSN/Reuters
Wednesday, April 23, 2025 - 10:27pm
tags:
Zealand Pharma, Eli Lilly, obesity
Vanda sues FDA over hearing delay as agency points to mass layoffs, other litigation with the biopharma
Fierce Biotech
Wednesday, April 23, 2025 - 10:23pm
tags:
Vanda Pharmaceuticals, FDA, legal, tradipitant
AstraZeneca pushes EU to spend more on drugs amid Trump tariffs threat
Yahoo Finance
Wednesday, April 23, 2025 - 6:54pm
tags:
AstraZeneca, Europe, Pharma CEOs, tariffs, Donald Trump, Pascal Soriot
Biotech’s ‘nauseating roller coaster’ repels investors
BioSpace
Wednesday, April 23, 2025 - 11:12am
tags:
biotech, tariffs, investors
European pharma companies push for higher drug prices in EU amid U.S. tariff threats
Pharma Live
Wednesday, April 23, 2025 - 11:09am
tags:
Europe, tariffs, drug pricing
German cancer antibody biotech eyes SPAC as route to Nasdaq
Fierce Biotech
Wednesday, April 23, 2025 - 11:02am
tags:
Veraxa, SPACs, NASDAQ, cancer
Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro
CNBC
Wednesday, April 23, 2025 - 11:01am
tags:
Eli Lilly, legal, telehealth, compounded drugs, Mounjaro, Zepbound
Ascletis sees no benefit to high, fast oral GLP-1 dose titration, takes low, slow regimen forward
Fierce Biotech
Wednesday, April 23, 2025 - 10:59am
tags:
Ascletis, clinical trials, ASC30
Novavax reveals FDA request for additional data
Investing.com
Wednesday, April 23, 2025 - 9:54am
tags:
Novavax, vaccines, COVID-19, FDA
Roche looks to a Flagship startup in search of new immune drugs
BioPharma Dive
Wednesday, April 23, 2025 - 9:50am
tags:
Roche, Repertoire Immune Medicines, Genentech, autoimmune disease
Synthetic Design Lab Emerges with $20M to Advance Next-Generation ADCs
Yahoo Finance
Wednesday, April 23, 2025 - 9:48am
tags:
Synthetic Design Lab, antibody-drug conjugate, funding
Sanofi hands back cancer NK cell engager to Innate amid autoimmune pivot
Fierce Biotech
Wednesday, April 23, 2025 - 9:47am
tags:
Sanofi, natural killer cells, Innate Pharma
Vaccine developers mobilize amid "great unraveling" of their work
Axios
Wednesday, April 23, 2025 - 9:44am
tags:
vaccines, drug development, HHS, Donald Trump, Robert F Kennedy Jr.
Boehringer to expand oncology presence with $572m Tessellate Bio deal
Pharmaceutical Technology
Wednesday, April 23, 2025 - 9:42am
tags:
Boehringer Ingelheim, Tessellate Bio, cancer, oncology, telomeres
Axtria unveils transformational agentic AI platform for life sciences
Pharmaphorum
Wednesday, April 23, 2025 - 9:40am
tags:
Axtria, artificial intelligence, InsightsMAx.ai
Bausch Health, after setting up 'poison pill' defense, reveals activist investor Carl Icahn's 34% interest
Fierce Pharma
Tuesday, April 22, 2025 - 7:45pm
tags:
Bausch Health, poison pill, Carl Icahn
RFK Jr. eyes reversing CDC’s Covid-19 vaccine recommendation for children
Politico
Tuesday, April 22, 2025 - 7:43pm
tags:
COVID-19, vaccines, pediatrics, HHS, Robert F Kennedy Jr.
Why Vertex Pharmaceuticals Was Such a Healthy Stock on Tuesday
Motley Fool
Tuesday, April 22, 2025 - 7:42pm
tags:
Vertex Pharmaceuticals
One of Medtech's Top 100 Companies Is Moving Away from the Diabetes Space
Medical Devices and Diagnostics Industry
Tuesday, April 22, 2025 - 7:41pm
tags:
Medtech, Ypsomed, diabetes, TecMed

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.